Acute Application of Pegvisomant and Octreotide in Acromegaly

NCT00595140 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: pegvisomant
DRUG: combination with somatostatin analogue octreotide
DRUG: combination with dopamine agonist cabergoline

Sponsor

Ludwig-Maximilians - University of Munich